Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis Under Conditions of Standard Practice in the Czech Republic

Trial Profile

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis Under Conditions of Standard Practice in the Czech Republic

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Oct 2013

At a glance

  • Drugs Mesalazine (Primary)
  • Indications Ulcerative colitis
  • Focus Adverse reactions
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 19 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 29 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top